Literature DB >> 11564246

Are nonfunctioning pituitary adenomas extending into the cavernous sinus aggressive and/or invasive?

S Yokoyama1, H Hirano, K Moroki, M Goto, S Imamura, J I Kuratsu.   

Abstract

OBJECTIVE: We studied nonfunctioning pituitary adenomas extending to the cavernous sinus to gain insight into the discrepancy between their histologically benign nature and frequent extension into the cavernous sinus.
METHODS: We studied 10 patients with nonfunctioning pituitary adenomas that completely encircled the cavernous carotid artery (extension group). All 10 patients underwent surgery to remove intrasellar and/or suprasellar parts of the adenomas. Ten patients with nonfunctioning pituitary adenomas without cavernous sinus extension comprised the control group. Tumor size follow-up data were obtained by magnetic resonance imaging. Immunostaining was performed for Ki-67, cathepsin B, and matrix metalloprotainase-9. To assess the wall thickness, 10 cavernous sinuses were removed from the cranial base of adult cadavers, and the walls were examined histologically.
RESULTS: Magnetic resonance imaging demonstrated no remarkable growth in most of the patients during the follow-up period (mean, 65.8 mo). There was no statistical difference in Ki-67, cathepsin B, and matrix metalloprotainase-9 immunostaining between the extension group and the control group. The cadaver study demonstrated that the medial wall was significantly thinner than the superior and the lateral walls (P < 0.0005). We found small defects in the capsule histologically in 3 of 30 sections.
CONCLUSION: Our results indicate that most of nonfunctioning pituitary adenomas extending into the cavernous sinus are neither aggressive nor invasive. The high incidence of cavernous sinus extension of benign adenomas may be caused by the weakness of the medial wall of the cavernous sinus.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11564246     DOI: 10.1097/00006123-200110000-00014

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  25 in total

1.  Isolated sixth cranial nerve palsy as the presenting symptom of a rapidly expanding ACTH positive pituitary adenoma: a case report.

Authors:  Norman Saffra; Elizabeth Kaplow; Irina Mikolaenko; Alice Kim; Benjamin Rubin; Jafar Jafar
Journal:  BMC Ophthalmol       Date:  2011-01-27       Impact factor: 2.209

Review 2.  Cavernous sinus medial wall: dural or fibrous layer? Systematic review of the literature.

Authors:  Mariangela Barbi Gonçalves; Jean Gonçalves de Oliveira; Hillary Ann Williams; Regina Maria Papais Alvarenga; José Alberto Landeiro
Journal:  Neurosurg Rev       Date:  2011-10-19       Impact factor: 3.042

3.  Endoscopic anatomy and approaches of the cavernous sinus: cadaver study.

Authors:  Bashar Abuzayed; Necmettin Tanriover; Nurperi Gazioglu; Fatma Ozlen; Gursel Cetin; Ziya Akar
Journal:  Surg Radiol Anat       Date:  2010-04-29       Impact factor: 1.246

4.  Matrix metalloproteinase-9 is differentially expressed in nonfunctioning invasive and noninvasive pituitary adenomas and increases invasion in human pituitary adenoma cell line.

Authors:  Isa M Hussaini; Christy Trotter; Yunge Zhao; Rana Abdel-Fattah; Samson Amos; Aizhen Xiao; Crystal U Agi; Gerard T Redpath; Zixing Fang; Gilberto K K Leung; Maria Beatriz S Lopes; Edward R Laws
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

5.  Matrix metalloproteinase 2 (MMP-2) levels are increased in active acromegaly patients.

Authors:  Alper Cagri Karci; Zeynep Canturk; Ilhan Tarkun; Berrin Cetinarslan
Journal:  Endocrine       Date:  2017-03-22       Impact factor: 3.633

Review 6.  Emerging Histopathological and Genetic Parameters of Pituitary Adenomas: Clinical Impact and Recommendation for Future WHO Classification.

Authors:  W Saeger; S Petersenn; C Schöfl; U J Knappe; M Theodoropoulou; R Buslei; J Honegger
Journal:  Endocr Pathol       Date:  2016-06       Impact factor: 3.943

Review 7.  Diagnosis and treatment of refractory pituitary adenomas: a narrative review.

Authors:  Xiaohai Liu; Congxin Dai; Ming Feng; Mingchu Li; Ge Chen; Renzhi Wang
Journal:  Gland Surg       Date:  2021-04

8.  Matrix metalloproteinase-9, a potential biological marker in invasive pituitary adenomas.

Authors:  Jian Gong; Yunge Zhao; Rana Abdel-Fattah; Samson Amos; Aizhen Xiao; M Beatriz S Lopes; Isa M Hussaini; Edward R Laws
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

9.  Intraoperative optical identification of pituitary adenomas.

Authors:  M Sam Eljamel; Graham Leese; Harry Moseley
Journal:  J Neurooncol       Date:  2009-04-09       Impact factor: 4.130

10.  Reversion-inducing cysteine-rich protein with kazal motifs and matrix metalloproteinase-9 are prognostic markers in skull base chordomas.

Authors:  Nunung Nur Rahmah; Keiichi Sakai; Jun Nakayama; Kazuhiro Hongo
Journal:  Neurosurg Rev       Date:  2009-10-28       Impact factor: 3.042

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.